Miist Therapeutics Secures $7M to Develop Fast-Acting Medicine
Miist Therapeutics, a physics-based developer of inhaled medicines, today announced $7M in seed funding from investors including Refactor Capital, 1517 Fund, Freeflow Ventures, Entrepreneur First,...